Medical & Biological Laboratories Company Limited operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medical & Biological Laboratories Company Limited with three other
pharmaceutical manufacturers in Asia:
Dr. Lal PathLabs Ltd
sales of 9.12 billion Indian Rupees [US$142.33 million]
of which 100%
Thyrocare Technologies Ltd
(3.07 billion Indian Rupees [US$47.86 million]
Scandent Imaging Ltd
based in India
(17.98 million Indian Rupees [US$280,488.00 ]
Medical & Biological Laboratories Company Limited reported sales of ¥7.35 billion (US$67.02 million)
March of 2017.
decrease of 8.8%
versus 2016, when the company's sales were ¥8.06 billion.
Contributing to the drop in overall sales was the 8.8% decline
in Reagent Business, from ¥8.00 billion to ¥7.29 billion.
There were also decreases in sales in
Investment (down 1.4% to ¥60.17 million)